Skip to content

Asset turnover at other companies

Eli Lilly logo
Eli LillyLLY
0.7×+0.1×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
0.7×+0.2×
Arrowhead Research logo
Arrowhead ResearchARWR
0.3×-0.1×
Alkermes logo
AlkermesALKS
0.5×-0.2×
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
BridgeBio Pharma logo
BridgeBio PharmaBBIO
0.5×+0.4×

Other financials

Income statement

See full
Revenue$60.1M+83.8%
Gross profit$53.0M+82.3%
Operating income-$52.4M-11.4%
Net income-$55.6M-12.4%
EPS (diluted)-$0.83-2.5%

Balance sheet

See full
Cash & equivalents$62.1M-41.4%
Total debt$112.3M-1.1%
Total equity$122.9M+549%
Total assets$442.3M+14.4%

Cash flow

See full
Operating cash flow-$44.2M-9.5%
CapEx$238.3K
Free cash flow-$29.2M-2.4%

Valuation

See full
Market cap$6.64B+77.3%
Enterprise value$6.69B+78.4%
P/S30.6×+3.2×

Profitability

See full
Gross margin89.4%-0.2pp
Operating margin-90.9%-19.8pp
Net margin-93.3%-18.2pp
FCF margin-61.5%-14.1pp

Returns & leverage

See full
Return on equity-285.8%-68.9pp
Debt / equity0.9×-5.1×
Current ratio4.2×+0.9×

Where this comes from

Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s asset turnover?
Rhythm Pharmaceuticals, Inc. (RYTM) reported asset turnover of 0.5× in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
Rhythm Pharmaceuticals, Inc.'s asset turnover increased by 23.5% year-over-year, from 0.4× to 0.5×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.